Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins

Cholera is a severe diarrheal disease caused by the motile Gram-negative rod Vibrio cholerae. Live-attenuated V. cholerae vaccines harboring deletions of the genes encoding cholera toxin have great promise for reducing the global burden of cholera. However, development of live vaccines has been hampered by the tendency of such strains to induce noncholeric reactogenic diarrhea in human subjects. The molecular bases of reactogenicity are unknown, but it has been speculated that reactogenic diarrhea is a response to V. cholerae’s flagellum and/or the motility that it enables. Here, we used an infant rabbit model of reactogenicity to determine what V. cholerae factors trigger this response. We found that V. cholerae ctx mutants that produced flagellins induced diarrhea, regardless of whether the proteins were assembled into a flagellum or whether the flagellum was functional. In contrast, ∼90% of rabbits infected with V. cholerae lacking all five flagellin-encoding genes did not develop diarrhea. Thus, flagellin production, independent of flagellum assembly or motility, is sufficient for reactogenicity. The intestinal colonization and intraintestinal localization of the nonreactogenic flagellin-deficient strain were indistinguishable from those of a flagellated motile strain; however, the flagellin-deficient strain stimulated fewer mRNA transcripts coding for proinflammatory cytokines in the intestine. Thus, reactogenic diarrhea may be a consequence of an innate host inflammatory response to V. cholerae flagellins. Our results suggest a simple genetic blueprint for engineering defined nonreactogenic live-attenuated V. cholerae vaccine strains.

[1]  F. Qadri,et al.  Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991–2009 , 2009, Expert review of vaccines.

[2]  F. Yildiz,et al.  The Vibrio cholerae Flagellar Regulatory Hierarchy Controls Expression of Virulence Factors , 2009, Journal of bacteriology.

[3]  V. Viswanathan,et al.  Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea , 2009, Nature Reviews Microbiology.

[4]  J. Kaper,et al.  Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-κB Activation , 2008, Infection and Immunity.

[5]  Jun Zhu,et al.  Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing , 2008, Proceedings of the National Academy of Sciences.

[6]  C. Coban,et al.  Host innate immune receptors and beyond: making sense of microbial infections. , 2008, Cell host & microbe.

[7]  J. Holmgren,et al.  Cholera toxin structure, gene regulation and pathophysiological and immunological aspects , 2008, Cellular and Molecular Life Sciences.

[8]  J. Mekalanos,et al.  Decreased Potency of the Vibrio cholerae Sheathed Flagellum To Trigger Host Innate Immunity , 2008, Infection and Immunity.

[9]  A. Aderem,et al.  TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system , 2007, Seminars in Immunopathology.

[10]  M. Waldor,et al.  RNase E-dependent processing stabilizes MicX, a Vibrio cholerae sRNA , 2007, Molecular microbiology.

[11]  K. Klose,et al.  Identification of Proinflammatory Flagellin Proteins in Supernatants of Vibrio cholerae O1 by Proteomics Analysis*S , 2006, Molecular & Cellular Proteomics.

[12]  S. Calderwood,et al.  Live attenuated oral cholera vaccines , 2006, Expert review of vaccines.

[13]  M. Swanson,et al.  Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection , 2006, The Journal of experimental medicine.

[14]  W. Dietrich,et al.  Flagellin-Deficient Legionella Mutants Evade Caspase-1- and Naip5-Mediated Macrophage Immunity , 2006, PLoS pathogens.

[15]  M. Waldor,et al.  Activation of the Vibrio cholerae SOS Response Is Not Required for Intestinal Cholera Toxin Production or Colonization , 2006, Infection and Immunity.

[16]  C. Pothoulakis,et al.  Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Mathan,et al.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut , 2003, Gut.

[18]  P. Sansonetti,et al.  The Contribution of Accessory Toxins of Vibrio cholerae O1 El Tor to the Proinflammatory Response in a Murine Pulmonary Cholera Model , 2002, The Journal of experimental medicine.

[19]  John F. Heidelberg,et al.  Comparative genomic analysis of Vibrio cholerae: Genes that correlate with cholera endemic and pandemic disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  Z. Dossani,et al.  Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Häse,et al.  Flagellum-Independent Surface Migration ofVibrio cholerae and Escherichia coli , 2001, Journal of bacteriology.

[23]  S. Calderwood,et al.  Cholera vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Mekalanos,et al.  Copyright © 1998, American Society for Microbiology Differential Regulation of Multiple Flagellins in Vibrio cholerae , 1997 .

[25]  C. Tacket,et al.  New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae , 1996, Infection and immunity.

[26]  J. Mekalanos,et al.  Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression , 1996, Infection and immunity.

[27]  J. Kaper,et al.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.

[28]  D. Spriggs,et al.  Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. , 1995, The Journal of infectious diseases.

[29]  J. Ezzell,et al.  Development of a live, oral, attenuated vaccine against El Tor cholera. , 1994, The Journal of infectious diseases.

[30]  J. Mekalanos,et al.  Cholera vaccines: fighting an ancient scourge. , 1994, Science.

[31]  Amit Pal,et al.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.

[32]  J. Mekalanos,et al.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development , 1983, Nature.